Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $4.19 Million - $5.36 Million
15,897 New
15,897 $4.2 Million
Q2 2021

Aug 12, 2021

SELL
$372.36 - $412.07 $841,533 - $931,278
-2,260 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$357.26 - $392.57 $807,407 - $887,208
2,260 New
2,260 $868,000
Q2 2019

Aug 09, 2019

SELL
$279.29 - $336.89 $6 Million - $7.23 Million
-21,469 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$246.18 - $297.25 $5.29 Million - $6.38 Million
21,469 New
21,469 $6.36 Million
Q1 2018

May 03, 2018

SELL
$218.74 - $251.43 $3.44 Million - $3.96 Million
-15,746 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$217.88 - $244.43 $3.43 Million - $3.85 Million
15,746
15,746 $3.43 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.